SIRPA and neoplasm: Thus, innate checkpoint inhibition may enhance the anti-tumor effect of DNA damaging agents.CD47 is an immune checkpoint that binds signal regulatory protein alpha (SIRPα) and delivers a “do not eat” signal to suppress macrophage phagocytosis.